Aptose Biosciences | 4:持股变动声明- LEDRU PHILIPPE
Aptose Biosciences | SC 13D/A:超过5%持股股东披露文件(修正)-Hanmi Pharmaceutical Co., Ltd.(19.02%)
Aptose Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-Nantahala Capital Management, LLC(1.5%),Wilmot B. Harkey(1.5%)等
Aptose Biosciences | 4:持股变动声明-高管 Payne Fletcher
Aptose Biosciences | 4:持股变动声明-高管 Bejar Rafael
Aptose Biosciences | 4:持股变动声明-高管 LEDRU PHILIPPE
Aptose Biosciences | 4:持股变动声明-高管 Rice William G.
Aptose Biosciences | 4:持股变动声明-董事 Seizinger Bernd R.
Aptose Biosciences | 4:持股变动声明-董事 PLATZER ERICH
Aptose Biosciences | 4:持股变动声明-董事 Vincent Mark D.
Aptose Biosciences | 4:持股变动声明-董事 Ashe Carol Gail
Aptose Biosciences | 4:持股变动声明-董事 BURGER DENIS R
Aptose Biosciences | 4:持股变动声明-董事 Whitehead Warren
Aptose Biosciences | SC 13D/A:超过5%持股股东披露文件(修正)
Aptose Biosciences | 4:持股变动声明-董事 Seizinger Bernd R.
Aptose Biosciences | SC 13D:超过5%持股股东披露文件
Aptose Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-Nantahala Capital Management, LLC(6.6%),Wilmot B. Harkey(6.6%)等
Aptose Biosciences | 4:持股变动声明
Aptose Biosciences | 4:持股变动声明
Aptose Biosciences | 4:持股变动声明
暂无数据
暂无数据